Exploring Ketamine, Healthcare Dynamics, and the Rise of Tech Amid Crisis

This chapter explores the role of ketamine in treating depression amidst the backdrop of public health crises, particularly COVID-19. It examines rising healthcare expenditures, the shift to virtual work, and the financial successes of tech companies during the pandemic, highlighting the intersection of public health and corporate interests.